Abstract
Aretaeus (2nd century AD) coined the term “skirros”, because he thought that inflammation of the liver led to its hardening (=skirros). • In 1543 A. Vesal described the granulation of the liver surface as being responsible for the compression of the small hepatic vessels. Even at that time, he associated these changes, which were thought to accompany a shrinking of the liver, with alcohol consumption. • When J. Posthius (1590) described ascites, he said that the changed liver was “all granulated inside”. A drawing by J. Brown (1685) shows coarse nodular liver cirrhosis. G. B. Morgagni (1761) also wrote a treatise on cirrhosis, in which he described the small vessels as being compressed due to a shrinking and hardened liver. M. Baillie (1818) wrote an excellent description of the morphology of liver cirrhosis and, like A. Vesal, also postulated a causal connection with excessive alcohol consumption. The first accurate report on atrophic, portal cirrhosis was given by R.T.H. Laennec (1819) an incidental inclusion in his book “Traité ďauscultation”.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Acalovschi, M., Badea, R., Pascu, M.: Incidence of gallstones in liver cirrhosis. Amer. J. Gastroenterol. 1991; 86: 1179–1181
Adler, M., Verset, D., Bouhdid, H., Bourgeois, N., Gulbis, B., Moine, O. le Stadt, J., van de Gelin, M., Thiry, P.: Prognostic evaluation of patients with parenchymal cirrhosis. J. Hepatol. 1997; 26: 642–649
Agusti, A.G.N., Roca, J., Bosch, J., Rodriguez-Roisin : The lung in patients with cirrhosis. J. Hepatol. 1990; 10: 251–257
Al Hamoudi, W., Lee, S.S.: Cirrhotic cardiomyopathy. (review). Ann. Hepatol. 2006, 5: 132–139
Al Sarela, Mihaimeed, F.M.A., Batten, J.J., Davidson, B.R., Mathie, R.T.: Hepatic and splanchnic nitric oxide activity in patients with cirrhosis. Gut 1999; 44: 749–753
Aller, R., Moya, J.L., Moreira, V., Boixeda, D., Picher, J., Garcia-Rull, S., de Luis, D.A.: Etiology and frequency of gas exchange abnormalities in cirrhosis. Rev. Esp. Enf. Digest. 1999; 91: 564–568
Alvaro, D., Angelico, M., Gandin, C., Corradini, S.G., Capocaccia, L.: Physico-chemical factors predisposing to pigment gallstone formation in liver cirrhosis. J. Hepatol. 1990; 10: 228–234
Amitrano, L., Guardascione, M.A., Brancaccio, V., Margaglione, M., Manguso, F., Iannaccone, L., Grandone, E., Balzano, A.: Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J. Hepatol. 2004; 40: 736–741
Amodio, P., del Piccolo, F., Marchetti, P., Angeli, P., Iemmolo, R., Caregaro, L., Merkel, O., Gerunda, G., Gatta, A.: Clinical features and survival of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests. Hepatology 1999; 29: 1662–1667
Angeli, P., Albino, G., Carraro, P., dalla Pria, M., Merkel, C., Caregaro, L., de Bei, E., Bortoluzzi, A., Plebani, M., Gatta, A.: Cirrhosis and muscle cramps: evidence of a causal relationship. Hepatology 1996; 23: 264–273
Angeli, P., Wong, F., Watson, H., Gines, P.: Hyponatremia in cirrhosis: Results of a patient population survey. Hepatology 2000; 44: 1535–1542
Anthony, P.P., Ishak, K.G., Nayak, N.C., Poulsen, H.E., Scheuer, P.J., Sobin, L.H.: The morphology of cirrhosis: definition, nomenclature and classification. Bull. WHO 1977; 55: 521–524
Arguedas, M.R., DeLawrence, T.G., McGuire, B.M.: Influence of hepatic encephalopathy on health-related quality of life in patients with cirrhosis. Dig. Dis. Sci. 2003; 48: 1622–1626
Arkenau, H.-T., Stichtenoth, D.O., Fröhlich, J.C., Manns, M.P., Böker, K.-H.W.: Elevated nitric oxide levels in patients with chronic liver disease and cirrhosis correlate with disease stage and parameters of hyperdynamic circulation. Z. Gastroenterol. 2002; 40: 907–912
Asbert, M., Gines, A., Gines, P., Jimenez, W., Claria, J., Salo, J., Arroyo, V., Rivera, F., Rodes, J.: Circulating levels of endothelin in cirrhosis. Gastroenterology 1993; 104: 1485–1491
Aubé, C., Oberti, F., Korali, N., Namour, M.A., Loisel, D., Tanguy, J.Y., Valsesia, E., Pilette, C., Rousselet, M.C., Bedossa, P., Rifflet, H., Maiga, M.Y., Penneau-Fontbonne, D., Caron, C., Cales, P.: Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis. J. Hepatol. 1999; 30: 472–478
Ayata, G., Gordon, F.D., Lewis, D., Pomfret, E., Pomposelli, J.J., Jenkins, R.L., Khettry, U.: Cryptogenic cirrhosis: Clinicopathologic findings at and after liver transplantation. Human Path. 2002; 33: 1098–1104
Bajaj, B.K., Agarwal, M.P., Ram, B.K.: Autonomic neuropathy in patients with hepatic cirrhosis. Postgrad. Med. J. 2003; 79: 408–411
Ballmer, P.E., Walshe, D., McNurlan, M.A., Watson, H., Brunt, P.W., Garlick, P.J.: Albumin synthesis rate in cirrhosis: correlation with Child-Turcotte classification. Hepatology 1993; 18: 292–297
Bandi, J.-C., Garcia-Pagan, J.C., Escorsell, A., Francois, E., Moithinho, E., Rodes, J., Bosch, J.: Effects of propranolol on the hepatic hemodynamic response to physical exercise in patients with cirrhosis. Hepatology 1998; 28: 677–682
Battista, S., Bar, F., Mengozzi, G., Zanon, E., Grosso, M., Molino, G.: Hyperdynamic circulation in patients with cirrhosis: direct measurement of nitric oxide levels in hepatic and portal veins. J. Hepatol. 1997; 26: 75–80
Belli, L., Sansalone, C.V., Aseni, P., Romani, F., Rondinara, G.: Portal thrombosis in cirrhosis. Ann. Surg. 1986; 203: 286–291
Bini, E.J., Lascarides, C.E., Micale, P.L., Weinshel, E.H.: Mucosal abnormalities of the colon in patients with portal hypertension: an endoscopic study. Gastrointest. Endosc. 2000; 52: 511–516
Bolognesi, M., Sacerdoti, D., Bombonato, G., Chiesura-Corona, M., Merkel, C., Gatta, A.: Arterioportal fistulas in patients with liver cirrhosis: usefullness of color Doppler US for screening. Radiology 2000; 216: 738–743
Boustière, C., Dumas, O., Jouffre, C., Letard, J.C., Patouillard, B., Etaix, J.P., Barthélémy, C., Audigier, J.C.: Endoscopic ultrasonography classification of gastric varices in patients with cirrhosis. Comparison with endoscopic findings. J. Hepatol. 1993; 19: 268–272
Brancatelli, G., Federle, M.P., Ambrosini, R., Lagala, R., Carriero, A., Midivi, M., Vilgrain, V.: Cirrhosis CT and MR imaging evaluation. Eur. J. Radiol. 2007; 61: 57–69
Brinch, K., Moller, S., Bendtsen, F., Becker, U., Henriksen, J.H.: Plasma volume expansion by albumin in cirrhosis. Relation to blood volume distribution, arterial compliance and severity of disease. J. Hepatol. 2003; 39: 24–31
Burch, R.E., Sackin, D.A., Ursick, J.A., Jetton, M.M., Sullivan, J.F.: Decreased taste and smell acuity in cirrhosis. Arch. Intern. Med. 1978; 138: 743–746
Bureau, C., Garcia-Pagan, J.C., Otal, P., Pomier-Layrargues, G., Chabbert, V., Cortez, C., Perreault, P., Peron, J.M., Abraldes, J.G., Bouchard, L., Bilbao, J.I., Bosch, J., Rousseau, H., Vinel, J.P.: Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: Results of a randomized study. Gastroenterology 2004; 126: 469–475
Burk, R.F., Early, D.S., Hill, K.E., Palmer, I.S., Boeglin, M.E.: Plasma selenium in patients with cirrhosis. Hepatology 1998; 27: 794–798
Cabrè, E., Abad-Lacruz, A., Numez, M.C., Gonzalez-Huix, F., Fernandez-Banares, F., Gil, A., Esteve-Comas, M., Moreno, J., Planas, R., Guilera, M., Gassull, M.A.: The relationship of plasma polyunsaturated fatty acid deficiency with survival in advanced liver cirrhosis: multivariate analysis. Amer. J. Gastroenterol. 1993; 88: 718–722
Cabrè, E., Gonzalez-Huix, F., Abad-Lacruz, A., Esteve, M., Acero, D., Fernandez-Banares, F., Xiol, X., Gassull, M.A.: Effect of total enteral nutrition on the short-term outcome of severely malnourished cirrhotics. A randomized controlled trial. Gastroenterology 1990; 98: 715–720
Caldwell, S.H., Oelsner, D.H., Iezzoni, J.C., Hespenheide, E.E., Battle, E.H., Driscoll, C.J.: Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 1999; 29: 664–669
Caly, W.R., Strauss, E.: A prospective study of bacterial infectious in patients with cirrhosis. J. Hepatol. 1993; 18: 353–358
Campillo, B., Bories, P., Devanlay, M., Sommer, F., Wirzuin, E., Fouet, P.: The thermogenic and metabolic effect of food in liver cirrhosis: Consequences on the storage of nutrients and the hormonal counter-regulatory response. Metabolism 1992; 41: 472–482
Campillo, B., Bories, P.N., Benvenuti, C., Dupeyron, C.: Serum and urinary nitrate levels in liver cirrhosis: endotoxemia, renal function and hyperdynamic circulation. J. Hepatol. 1996; 25: 707–714
Campollo, O., Sprengers, D., McIntyre, N.: The BCAA/AAA ratio of plasma amino acids in three different groups of cirrhotics. Rev. Invest. Clin. 1992; 44: 513–518
Cardenas, A., Kelleher, T., Chopra, S.: Review article: hepatic hydrothorax. Aliment. Pharmacol. Ther. 2004; 20: 271–279
Chan, C.C., Hwang, S.J., Lee, F.Y., Wang, S.S., Chang, F.Y., Li, C.P., Chu, C.J.: Prognostic value of plasma endotoxin levels in patients with cirrhosis. Scand. J. Gastroenterol. 1997; 32: 942–946
Channick, R.N., Simonneau, G., Sitbon, O., Robbins, I.M., Frost, A., Tapson, V.F., Badesch, D.B., Roux, S., Rainisio, M., Bodin, F., Rubin, L.J.: Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomized placebo-controlled study. Lancet 2001; 358: 1119–1123
Chen, A., Ho, Y., Tu, Y., Tang, H., Cheng, T.: Diaphragmatic defect as a cause of massive hydrothorax in cirrhosis of the liver. J. Clin. Gastroenterol. 1988; 10: 663–666
Colli, A., Fraquelli, M., Andreoletti, M., Marino, B., Zuccoli, E., Conte, D.: Severe liver fibrosis or cirrhosis: Accuracy of US for detection. — Analysis of 300 cases. Radiology 2003; 227: 89–94
Conte, D., Fraquell, M., Fornari, F., Lodi, L., Bodini, P., Buscarini, L.: Close relation between cirrhosis and gallstones. Arch. Intern. Med. 1999; 159: 49–52
Cordoba, J., Cabrera, J., Lataif, L., Penev, P., Zel, P., Blei, H.T.: High prevalence of sleep disturbance in cirrhosis. Hepatology 1998; 27: 339–345
D’Amico, G., Montalbano, L., Traina, M., Pisa, R., Menozzi, M., Spano, C., Pagliaro, L.: Natural history of congestive gastropathy in cirrhosis. Gastroenterology 1990; 99: 1558–1564
Debernardi-Venon, W., Barletti, C., Alessandria, C., Marzano, A., Baronio, M., Todros, L., Saracco, G., Repici, A., Rizzetto, M.: Efficacy of irbesartan, a receptor selective antagonist of angiotensin II, in reducing portal hypertension. Dig. Dis. Sci. 2002; 47: 401–404
Degre, D., Bourgeois, N., Boon, N., LeMoine, O., Louis, H., Donckier, V., El Nakadi, I., Closset, J., Lingier, P., Vereerstraeten, P., Gelin, M., Adler, M.: Aminopyrine breath test compared to the MELD and Child-Pugh scores for predicting mortality among cirrhotic patients awaiting liver transplantation. Transplant. Internat. 2004; 17: 31–38
Del Olmo, J.A., Garcia, F., Serra, M.A., Maldonado, L., Rodrigo, J.M.: Prevalence and incidence of gallstones in liver cirrhosis. Scand. J. Gastroenterol. 1997; 32: 1061–1065
Del Olmo, J.A., Serra, M.A., Rodriguez, F., Escudero, S., Gilabert, S., Rodrigo, J.M.: Incidence and risk factors for hepatocellular carcinoma in 967 patients with cirrhosis. J. Canc. Res. Clin. Oncol. 1998; 124: 560–564
Denzer, U., Arnoldy, A., Kanzler, S., Galle, P.R., Dienes, H.P., Lohse, A.W.: Prospective randomized comparison of minilaparoscopy and percutaneous liver biopsy: Diagnosis of cirrhosis and complications. J. Clin. Gastroenterol. 2007; 41: 103–110
Desmet, V.J., Sciot, R., van Eyken, P.: Differential diagnosis and prognosis of cirrhosis: role of liver biopsy. Acta Gastroenterol. Belg. 1990; 53: 198–208
Dhiman, R.K., Sawhney, I.M.S., Chawla, Y.K., Das, G., Ram, S., Dilawari, J.B.: Efficacy of lactulose in cirrhotic patients with subclinical hepatic encephalopathy. Dig. Dis. Sci. 2000; 45: 1549–1552
Di Lelio, A., Cestari, C., Lomazzi, A., Beretta, L.: Cirrhosis: diagnosis with sonographic study of the liver surface. Radiology 1989; 172: 389–392
Diamond, T.H., Stiel, D., Lunzer, M., McDowall, D., Eckstein, R.P., Posen, S.: Hepatic osteodystrophy. Static and dynamic bone histomorphometry and serum bone Gla-Protein in 80 patients with chronic liver disease. Gastroenterology 1989; 96: 213–221
Duchini, A., Viernes, M.E., Nyberg, L.M., Hendry, R.M., Pockros, P.J.: Hepatic decompensation in patients with cirrhosis during infection with influenza A. Arch. Intern. Med. 2000; 160: 113–115
Essers, U., Bleifeld, W., Kaiser, E.: Rezidivierendes Fieber und Erhöhung des ungebundenen Ätiocholanolons im Blut. Dtsch. Med. Wschr. 1971; 96: 107–117
Fernandez, J., Navasa, M., Gomez, J., Colmenero, J., Vila, J., Arroyo, V., Rodes, J.: Bacterial infections in cirrhosis. Epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 2002; 35: 140–148
Ferrante, D., Arguedas, M.R., Cerfolio, R.J., Collins, B.G., van Leeuwen, D.J.: Video-assisted thoracoscopy surgery with talc pleurodesis in the management of symptomatic hepatic hydrothorax. Amer. J. Gastroenterol. 2002; 97: 3172–3175
Gaiani, St., Bolondi, L., li Bassi, S., Zironi, G., Siringo, S., Barbara, L.: Prevalence of spontaneous hepatofugal portal flow in liver cirrhosis. Clinical and endoscopic correlation in 228 patients. Gastroenterology 1991; 100: 160–167
Gaune-Carrie, N., Ziol, M., de Ledinghen, V., Douvin, C., Marcellin, P., Castera, L., Drumeaux, D., Truchet, J.C., Beaugrand, M.: Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology 2006; 44: 1511–1517
Garcia-Pagán, J., Santos, C., Barberá, J.A., Luca, A., Roca, J., Rodriguez-Roisin, R., Bosch, J., Rodés, J.: Physical exercise increases portal pressure in patients with cirrhosis and portal hypertension. Gastroenterology 1996; 111: 1300–1306
Garcia-Pagan, J.C., Morillas, R., Banares, R., Albillos, A., Villanueva, C., Vila, C., Genesca, J., Jimenez, M., Rodriguez, M., Calleja, J.L., Balanzo, J., Garcia-Duran, F., Planas, R., Bosch, J.: Propranolol plus placebo versus propranolol plus isosorbide-5-mononitrate in the prevention of a first variceal bleed: A double-blind RCT. Hepatology 2003; 37: 1260–1266
Giouleme, O.I., Vyzantiadis, T.A., Nikolaidis, N.L., Vasiliadis, T.G., Papageorgiou, A.A., Eugenidis, N.P., Harsoulis, F.I.: Pathogenesis of osteoporosis in liver cirrhosis. Hepato-Gastroenterology 2006; 53: 936–943
Golli, M., Kriaa, S., Said, M., Belguith, M., Zbidi, M., Saad, J., Nouri, A., Ganouni, A.: Intrahepatic spontaneous portosystemic venous shunt: value of color and power Doppler sonography. J. Clin. Ultrasound 2000; 28: 47–50
Graudal, N., Leth, P., Marbjerg, L., Galloe, A.M.: Characteristics of cirrhosis undiagnosed during life: a comparative analysis of 73 undiagnosed cases and 149 diagnosed cases of cirrhosis, detected in 4929 consecutive autopsies. J. Intern. Med. 1991; 230: 165–171
Greco, A.V., Mingrone, G., Benedetti, G., Capristo, E., Tataranni, P.A., Gasbarrini, G.: Daily energy and substrate metabolism in patients with cirrhosis. Hepatology 1998; 27: 346–350
Gur, C., Ilan, Y., Shibolet, O.: Hepatic hydrothorax. Pathophysiology, diagnosis and treatment. Review of the literature. Liver Internat. 2004; 24: 281–284
Guslandi, M., Foppa, L., Soirghi, M., Pellegrini, A., Fanti, L., Tittobello, A.: Breakdown of mucosal defences in congestive gastropathy in cirrhotics. Liver 1992; 12: 303–305
Habu, D., Nishiguchi, S., Nakatani, S., Kawamura, E., Lee, C., Enomoto, M., Tamori, A., Takeda, T., Tanaka, T., Shiomi, S.: Effect of oral supplementation with branched-chain amino acid granules on serum albumin level in the early stage of cirrhosis: a randomized pilot trial. Hepatol. Res. 2003; 25: 312–318
Haitjema, T., de Maat, C.E.M.: Pleural effusion without ascites in a patient with cirrhosis. Neth. J. Med. 1994; 44: 207–209
Herold, C., Heinz, R., Radespiel-Tröger, M., Schneider, H.T., Schuppan, D., Hahn, E.G.: Quantitative testing of liver function in patients with cirrhosis due to chronic hepatitis C to assess disease severity. Liver 2001; 21: 26–30
Herve, P., Le Pavec, J., Sztrymf, B., Decante, B., Savale, L., Sitbon, O.: Pulmonary vascular abnormalities in cirrhosis. Best Pract. Res. Clin. Gastroenterol. 2007; 21: 141–159
Hicken, B.L., Sharara, A.I., Abrams, G.A., Eloubeidi, M., Fallon, M.B., Arguedas, M.R.: Hepatic venous pressure gradient measurements to assess response to primary prophylaxis in patients with cirrhosis: A decision analytical study. Alim. Pharm. Ther. 2003; 17: 145–153
Hosking, S.W., Smart, H.L., Johnson, A.G., Triger, D.R.: Anorectal varices, hemorrhoids, and portal hypertension. Lancet 1989/I: 349–352
Hourani, J.M., Bellamy, P.E., Tashkin, D.P., Batra, M.S., Simmons, M.S.: Pulmonary dysfunction in advanced liver disease. Frequent occurrence of an abnormal diffusing capacity. Amer. J. Med. 1991; 90: 693–700
Huang, L.Y., Cui, J., Wu, C.R., Liu, Y.X.: Embolization combined with endoscopic variceal ligation for the treatment of oesophagogastric variceal bleeding in patients with cirrhosis. Clin. Med. J. 2007; 107: 36–40
Idilman, R., de Maria, N., Uzunalimoglu, O., van Thiel, D.H.: Hepatic osteodystrophy: a review. Hepatogastroenterology 1997; 44: 474–581
Ikegami, M., Toyonaga, A., Tanikawa, K.: Reduction of portal pressure by chronic administration of isosorbide dinitrate in patients with cirrhosis: effects on systemic and splanchnic hemodynamics and liver function. Amer. J. Gastroenterol. 1992; 87: 1160–1164
Ito, K., Mitchell, D.G.: Hepatic morphologic changes in cirrhosis: MR imaging findings. Abdom. Imag. 2000; 25: 456–461
Iwasa, M., Matsumura, K., Watanabe, Y., Yamamoto, M., Kaito, M., Ikoma, J., Gabazza, E.C., Takeda, K., Adachi, Y.: Improvement of regional cerebral blood flow after treatment with branched-chain amino acid solutions in patients with cirrhosis. Eur. J. Gastroenterol. Hepatol. 2003; 15: 733–737
Jongh, de, F.E., Janssen, H.L.A., de Man, R.A., Hop, W.C.J., Schalm, S.W., van Blankenstein, M.: Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver. Gastroenterology 1992; 103: 1630–1635
Kanematsu, M., Hoshi, H., Murakami, T., Inaba, Y., Kim, T., Yamada, T., Kato, M., Yokoyama, R., Nakamura, H.: Detection of hepatocellular carcinoma in patients with cirrhosis: MR imaging versus angiographically assisted helical CT. Amer. J. Roentg. 1997; 169: 1507–1515
Kanematsu, M., Hoshi, H., Yamada, T., Kim, T., Kato, M., Yokoyama, R., Nakamura, H.: Small hepatic nodules in cirrhosis: ultrasonographic, CT, and MR imaging findings. Abdom. Imag. 1999; 24: 47–55
Kaya, D., Kockar, M.C., Bavbek, N., Dagli, M., Kovar, A.: Cardiac dysfunction in cirrhosis. Hepatol. Res. 2003; 26: 181–185
Kharbanda, P.S., Prabhakas, S., Chawla, Y.K., Das, C.P., Syal, P.: Peripheral neuropathy in liver cirrhosis. J. Gastroenterol. Hepat. 2003; 18: 922–926
Kim, Y.J., Raman, S.S., Yu, N.C., TO’o, K.J., Jutabha, R., Lu, D.S.: Esophageal varices in cirrhotic patients: Evaluation with liver CT. Amer. J. Roentgenol. 2007; 188: 139–144
Kondrup, J., Nielsen, K., Juul, A.: Effect of long-term refeeding on protein metabolism in patients with cirrhosis of the liver. Brit. J. Nutr. 1997; 77: 197–212
Körner, T., Kropf, J., Kosche, B., Kristahl, H., Jaspersen, D., Gessner, A.M.: Improvement of prognostic power of the Child-Pugh classification of liver cirrhosis by hyaluronan. J. Hepatol. 2003; 39: 947–953
Kuntz, E.: Systematik und Ätiologie der Leberzirrhose. Münch. Med. Wschr. 1984; 126: 983–987
Kuntz, E.: 30 Jahre Erfahrung bei 6000 Laparoskopien (1955–1986). Fortschr. Med. 1987; 105: 521–524
Kuntz, E.: Klinische Aspekte, Prognose und Therapie der Leberzirrhose. Lebensversicherungsmed. 1990; 42: 52–55
Kuntz, E.: Der aktuelle Stellenwert der Laparoskopie in der Hepatologie. Med. Welt 1999; 50: 42–47
Lafortune, M., Matricardi, L., Denys, A., Favret, M., Déry, R., Ponnier-Layrargues, G.: Segment 4 (the quadrate lobe): a barometer of cirrhotic liver disease at US. Radiology 1998; 206: 157–160
Larcos, G., Sorokopud, H., Berry, G., Farell, G.C.: Sonographic screening for hepatocellular carcinoma in patients with chronic hepatitis or cirrhosis: an evaluation. Amer. J. Roentg. 1998; 171: 433–435
Le Bail, B., Bernard, P.-H., Carles, J., Balabaud, C., Bioulac-Sage, P.: Prevalence of liver cell dysplasia and association with HCC in a series of 100 cirrhotic liver explants. J. Hepatol. 1997; 27: 835–842
Lenz, K., Hörtnagel, H., Druml, W., Reither, H., Schmid, R., Schneeweiss, B., Laggner, A., Grimm, G., Gerbes, A.L.: Ornipressin in the treatment of functional renal failure in decompensated liver cirrhosis. Effects on renal hemodynamics and atrial atriuretic factor. Gastroenterology 1991; 101: 1060–1067
Lirussi, F., Nassuato, G., Orlando, R., Iemmolo, R.M., Beccarello, A., Bortolato, L., Rusticali, A.G., Okolicsanyi, L.: Treatment of active cirrhosis with ursodeoxycholic acid and a free radical scavenger: a two year prospective study. Med. Sci. Res. 1995; 23: 31–33
Liu, Q., Duan, Z.P., Ha, D.K., Bengmark, S., Kurtovic, J., Riordan, S.M.: Synbiotic modulation of gut flora: Effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 2004; 39: 1441–1449
Ludwig, J., Hashimoto, E., Porayko, M.K., Moyer, T.P., Baldus, W.P.: Hemosiderosis in cirrhosis: a study of 447 native livers. Gastroenterology 1997; 112: 882–888
Malnick, S.D.H., Attali, M., Israeli, E., Gratz, R., Geltner, D.: Spontaneous bacterial arthritis in a cirrhotic patient. J. Clin. Gastroenterol. 1998; 27: 364–366
Marcato, N., Abergel, A., Alexandre, M., Boire, J.Y., Darcha, C., Duchene, B., Chipponi, J., Boyer, L., Viallet, J.F., Bommelaer, G.: Hepatocellular carcinoma in patients with cirrhosis: performance and semiology of magnetic resonance imaging and lipiodol computerized tomography. Gastroenterol. Clin. Biol. 1999; 23: 114–121
Marchesini, G., Bianchi, G., Merli, M., Amodio, P., Panella, C., Loguericio, C., Rossi Fanelli, F., Abbiati, R.: Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: A double-blind randomized trial. Gastroenterology 2003; 124: 1792–1801
Marchesini, G., Bugianesi, E., Ronchi, M., Flamia, R., Thomaseth, K., Pacini, G.: Zinc supplementation improves glucose disposal in patients with cirrhosis. Metabolism 1998; 47: 792–798
Marti-Bonmati, L., Talens, A., del Olmo, J., del Val, A., Serra, M., Rodrigo, J.M., Fernandez, A., Torres, V., Rayon, M.: Chronic hepatitis and cirrhosis. Evaluation by means of MR imaging with histological correlation. Radiology 1993; 188: 37–43
Matsuoka, C., Tanaka, N., Arakawa, Y.: Beneficial effects of branchedchain amino acids on altered protein and amino acid metabolism in liver cirrhosis: Evaluation in a model of liver cirrhosis induced in rats with carbon tetrachloride. Hepatol. Res. 2003; 27: 117–123
Merkel, C., Marin, R., Angeli, P., Zanella, P., Felder, M., Bernardinello, E., Cavalarin, G., Bolognesi, M., Donada, C., Bellini, B., Torboli, P., Gatta, A.: A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis. Gastroenterology 2004; 127: 476–484
Michl, P., Gülberg, V., Bilzer, M., Waggershauser, T., Reiber, M., Gerbes, A.L.: Transjugular intrahepatic portosystemic shunt for cirrhosis and ascites: effects in patients with organic or functional renal failure. Scand. J. Gastroenterol. 2000; 35: 654–658
Molle, I., Thulstrup, A.M., Svendsen, N., Schonheyder, H.C., Sorensen, H.T.: Risk and case fatality rate of meningitis in patients with liver cirrhosis. Scand. J. Infect. Dis. 2000; 32: 407–410
Morillas, R.M., Planas, R., Cabré, E., Galan, A., Quer, J.C., Feu, F., Garcia Pagan, J.C., Bosch, J., Gassull, M.A.: Propranolol plus isosorbid-5-mononitrate for portal hypertension in cirrhosis: long term hemodynamic and renal effects. Hepatology 1994; 20: 1502–1508
Morrison, W.L., Bouchier, I.A.D., Gibson, J.N.A., Rennie, M.J.: Skeletal muscle and whole-body protein turnover in cirrhosis. Clin. Sci. 1990; 78: 613–619
Müller, M.J.: Malnutrition in cirrhosis. J. Hepatol. 1995; 23 (Suppl. 1): 31–35
Murata, K., Shimizu, A., Takase, K., Nakano, T., Tameda, Y.: Asymptomatic primary pulmonary hypertension associated with liver cirrhosis. J. Gastroenterol. 1997; 32: 102–104
Murawaki, Y., Kobayashi, M., Koda, M., Kawasakia, H.: Effects of lactulose on intestinal bacterial flora and fecal organic acids in patients with liver cirrhosis. Hepatol. Res. 2000; 17: 56–64
Nagata, N., Miyachi, H., Nakano, A., Nanri, K., Kobayashi, H., Matsuzaki, S.: Sonographic evaluation of the anterior liver surface in chronic liver diseases using a 7.5-MHz annular-array transducer: correlation with laparoscopic and histopathologic findings. J. Clin. Ultrasound 2003; 31: 393–400
Nakamura, I., Ochiai, K., Imawari, M.: Phagocytic function of neutrophils of patients with decompensated cirrhosis is restored by oral supplementation of branched-chain amino acids. Hepatol. Res. 2004; 29: 207–211
Navasa, M., Fernandez, J., Rodes, J.: Bacterial infections in liver cirrhosis. Ital. J. Gastroenterol. 1999; 31: 616–625
Nord, H.J.: Biopsy diagnosis of cirrhosis: blind percutaneous versus guided direct vision techniques — a review. Gastrointest. Endosc. 1982; 28: 102–104
Oellerich, M., Burdelski, M., Lautz, H.U., Schulz, M., Schmidt, F.W., Herrmann, H.: Lidocaine metabolite formation as a measure of liver function in patients with cirrhosis. Ther. Drug Monit. 1990; 12: 219–226
Ogusu, T., Iwakiri, R., Sakata, H., Matsunaga, K., Shimoda, R., Oda, K., Watanabe, K., Ootani, H., Kikkawa, A., Ootani, A., Tsunada, S., Fujimoto, K.: Endoscopic injection sclerotherapy for esophageal varicces in cirrhotic patients without hepatocellular carcinoma: A comparison of long-term survival between prophylactic therapy and emergency therapy. J. Gastroenterol. 2003; 38: 361–364
Okamoto, M., Sakaida, I., Tsuchiya, M., Suzuki, C., Okita, K.: Effect of a late evening snack on the blood glucose level and energy metabolism in patients with liver cirrhosis. Hepatol. Res. 2003; 27: 45–50
Okuda, K., Ohnishi, K., Kimura, K., Matsutani, S., Sumida, M., Goto, N., Musha, H., Takashi, M., Suzuki, N., Shinagawa, T., Suzukui, N., Ohtsuki, T., Arakawa, M., Nakashima, T.: Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients. Gastroenterology 1985; 89: 279–286
Ordinas, A., Escolar, G., Cirera, I., Viñas, M., Cobo, F., Bosch, J., Terés, J., Rodés, J.: Existence of a platelet-adhesion defect in patients with cirrhosis independent of hematocrit: studies under flow conditions. Hepatology 1996; 24: 1137–1142
Orlando, R., Lirussi, F., Okolicsanyi, L.: Laparoscopy and liver biopsy: further evidence that the two procedures improve the diagnosis of liver cirrhosis. J. Clin. Gastroenterol. 1990; 12: 47–52
Panés, J., Bordas, J.M., Pique, J.M., Bosch, J., Garcin-Pagan, J.C., Feu, F., Casaderall, M., Teres, J., Rodes, J.: Increased gastric mucosal perfusion in cirrhotic patients with portal hypertensive gastropathy. Gastroenterology 1992; 103: 1875–1882
Pantaleo, P. Marra, F., Vizzutti, F., Spardoni, S., Ciabattoni, G., Galli, C., la Villa, G., Gentilini, P., Laffi, G.: Effects of dietary supplementation with arachidonic acid on platelet and renal function in patients with cirrhosis. Clin. Sci. 2004; 106: 27–34
Pauwels, A., Pines, E., Abboura, M., Chiche, I., Levy, V.-G.: Bacterial meningitis in cirrhosis — review of 16 cases. J. Hepatol. 1997; 27: 830–834
Payen, J.-L., Cales, P., Voigt, J.-J., Barbe, S., Pilette, C., Dubuisson, L., Desmorat, H., Vinel, J.-P., Kervran, A., Chayvialle, J.-A., Pascal, J.-P.: Severe portal hypertensive gastropathy and antral vascular ectasia are distinct entities in patients with cirrhosis. Gastroenterology 1995; 108: 138–144
Pellicano, R., Leone, N., Berrutti, M., Cutufia, M.A., Fiorentino, M., Rizzetto, M., Ponzetto, A.: Helicobacter pylori seroprevalence in hepatitis C virus positive patients with cirrhosis. J. Hepatol. 2000; 33: 648–650
Peltekian, K.M., Wong, F., Liu, P.P., Logan, A.G., Sherman, M., Blendis, L.M.: Cardiovascular, renal and neurohumoral response to single large-volume paracentesis in patients with cirrhosis and diureticresistant ascites. Amer. J. Gastroenterol. 1997; 92: 394–399
Plewe, G., Beyer, J.: Ätiocholanolon und Fieber. Dtsch. Med. Wschr. 1984; 109: 589–591
Poniachik, J., Bernstein, D.E., Reddy, K.R., Jeffers, L.J., Coelho-Little, M.-E., Civaertos, F., Schiff, E.R.: The role of laparoscopy in the diagnosis of cirrhosis. Gastrointest. Endosc. 1996; 43: 568–571
Poonawala, A., Nair, S.P., Thuluvath, P.J.: Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: A case-control study. Hepatology 2000; 32: 689–692
Powell, W.J., Klatskin, G.: Duration of survival in patients with Laennec’s cirrhosis. Amer. J. Med. 1968; 44: 406–420
Primignani, M., Carpinelli, L., Preatoni, P., Battaglia, G., Carta, A., Prada, A., Cestari, R., Angeli, P., Gatta, A., Rossi, A., Spinzi, G., de Franchis, R.: Natural history of portal hypertensive gastropathy in patients with liver cirrhosis. Gastroenterology 2000; 119: 181–187
Rasaratnam, B., Kaye, D., Jennings, G., Dudley, F., Chin-Dusting, J.: The effect of selective intestinal decontamination on the hyperdynamic circulatory state in cirrhosis. Ann. Intern. Med. 2003; 139: 186–193
Ratziu, V., Bonyhay, L., di Martino, V., Charlotte, F., Cavallaro, L., Savegh-Tainturier, M.H., Giral, P., Grimaldi, A., Opolon, P., Poynard, T.: Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis. Hepatology 2002; 35: 1485–1493
Realdi, G., Fattovich, G., Hadziyannis, S., Schalm, S.W., Almasio, P., Sanchez-Tapias, J., Christensen, E., Giustina, G., Noventa, F.: Survival and prognostic factors in 366 patients with compensated cirrhosis type B.: a multicenter study. J. Hepatol. 1994; 21: 656–666
Rees, C.J., Oppong, K., Al-Mardini, H., Hudson, M., Record, C.O.: Effect of L-ornithine-L-aspartate on patients with and without TIPS undergoing glutamine challenge: a double blind, placebo controlled trial. Gut 2000; 47: 571–574
Riehl, J., Bongartz, D., Nguyen, H., Sieberth, H.G.: Spontaneous portosystemic shunts in liver cirrhosis: demonstration by color coded Duplex ultrasonography. Ultraschall Med. 1997; 18: 272–276
Robalino, B.J., Moodie, D.S.: Association between primary pulmonary hypertension and portal hypertension: analysis of its pathophysiology and clinical, laboratory and hemodynamic manifestations. J. Amer. Coll. Cardiol. 1991; 17: 492–498
Saadeh, S., Behrens, P.W., Parsi, M.A., Carey, W.D., Connor, J.T., Grealis, M., Barnes, D.S.: The utility of the (13) C-galactose breath test as a measure of liver function. Alim. Pharm. Ther. 2003; 18: 995–1002
Sakai, K., Iwao, T., Oho, K., Toyonaga, A., Sata, M.: Propranolol ameliorates thrombocytopenia in patients with cirrhosis. J. Gastroenterol. 2002; 37: 112–118
Sako, K., Imamura, Y., Nishimata, H., Tahara, K., Kubozono, O., Tsubouchi, H.: Branched-chain amino acids supplements in the late evening decrease the frequency of muscle cramps with advanced hepatic cirrhosis. Hepatol. Res. 2003; 26: 327–329
Salerno, F., Borroni, G., Moser, P., Sangiovanni, A., Almasio, P., Budillon, G., Capuano, G., Muraca, M., Marchesini, G., Bernardi, M., Marenco, G., Molino, G., Rossaro, L., Solinas, A., Ascione, A.: Prognostic value of the galactose test in predicting survival of patients with cirrhosis evaluated for liver transplantation. J. Hepatol. 1996; 25: 474–480
Salo, J., Gines, A., Anibarro, L., Jimenez, W., Bataller, R., Claria, J., Gines, P., Rivera, F., Arroyo, V., Rodes, J.: Effect of upright posture and physical exercise on endogenous neurohormonal systems in cirrhotic patients with sodium retention and normal supine plasma renin, aldosterone, and norepinephrine levels. Hepatology 1995; 22: 479–487
Sangiovanni, A., Prati, G.M., Fasani, P., Ronchi, G., Romeo, R. Manini, M., del Ninno, E., Morabito, A., Colombo, M.: The natural history of compensated cirrhosis due to hepatitis C virus: A 17-year cohort study of 214 patients. Hepatology 2006; 43: 1303–1310
Santos, J., Planas, R., Pardo, A., Durandez, R., Cabre, E., Morillas, R.M., Granada, M.L., Jimenez, J.A., Quintero, E., Gassull, M.A.: Spironolacton alone or in combination with furosemide in the treatment of moderate ascites in non azotemic cirrhosis. A randomized comparative stucy of efficacy and safety. J. Hepatol. 2003; 39: 187–192
Sanyal, A.J., Freedman, A.M., Luketic, V.A., Purdum, P.P., Shiffman, M.L., Demeo, J., Cole, P.E., Tisnado, J.: The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts. Gastroenterology 1997; 112: 889–898
Saunders, J.B., Walters, J.R., Davies, A.P., Paton, A.: A 20 year prospective study of cirrhosis. Brit. Med. J. 1981; 282: 263–266
Scandalis, N., Archimandritis, A., Kastanas, K., Spiliadis, C., Delis, B., Manika, Z.: Colonic findings in cirrhotics with portal hypertension. J. Clin. Gastroenterol. 1994; 18: 325–329
Schenk, P., Madl, C., Rezaie-Majd, S., Lehr, S., Müller, C.: Methylene blue improves the hepatopulmonary syndrome. Ann. Intern. Med. 2000; 133: 701–706
Schenk, P., Schöniger-Hekele, M., Fuhrmann, V., Madl, C., Silberhumer, G., Müller, C.: Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. Gastroenterology 2003; 125: 1042–1052
Schepke, M., Kleber, G., Nürnberg, D., Willert, J., Koch, L., Veltzke-Schlieker, W., Hellerbrand, C., Kluth, J., Schanz, S., Kahl, S., Fleig, W.E., Sauerbruch, T.: Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology 2004; 40: 65–72
Schinella, M., Guglielmi, A., Veraldi, G.F., Boni, M., Frameglia, M., Caputo, M.: Evaluation of the liver function of cirrhotic patients based on the formation of monoethylglycine xylidide (MEGX) from lidocaine. Europ. J. Clin. Chem. Clin. Biochem. 1993; 31: 553–557
Scotinoitis, I.A., Lucey, M.R., Metz, D.C.: Helicobacter pylori infection is not associated with subclinical hepatic encephalopathy in stable cirrhotic patients. Dig. Dis. Sci. 2001; 46: 2744–2751
Shah, N.J., Neeb, H., Zaitsev, M., Steinhoff, S., Kircheis, G., Amunts, K., Häussinger, D., Zilles, K.: Quantitative T1 mapping of hepatic encephalopathy using magnetic resonance imaging. Hepatology 2003; 38: 1219–1226
Shmueli, E., Miell, J.P., Stewart, M., Alberti, K.G.M.M., Record, C.O.: High insulin-like growth factor binding protein 1 levels in cirrhosis: link with insulin resistance. Hepatology 1996; 24: 127–133
Shresta, R., McKinley, C., Showalter, R., Wilner, K., Marsano, L., Vivian, B.R., Everson, G.T.: Quantitative liver function tests define the functional severity of liver disease in early stage cirrhosis. Liver Transplant. Surg. 1997; 3: 166–173
Simonovsky, V.: The diagnosis of cirrhosis by high resolution ultrasound of the liver surface. Brit. J. Radiol. 1999; 72: 29–34
Siringo, S., Bolondi, L., Gaiani, St., Sofia, S., di Febo, G., Zironi, G., Rigamonti, A., Miglioli, M., Cavalli, G., Barbara, L.: The relationship of endoscopy, portal Doppler ultrasound flowmetry, and clinical and biochemical tests in cirrhosis. J. Hepatol. 1994; 20: 11–18
Siringo, S., Vaira, D., Menegatti, M., Piscaglia, F., Sofia, S., Gaetani, M., Miglioli, M., Corinaldesi, R., Bolondi, L.: High prevalence of Helicobacter pylori liver cirrhosis. Relationship with clinical and endoscopic features and the risk of peptic ulcer. Dig. Dis. Sci. 1997; 42: 2024–2030
Sorensen, T.I.A., Orholm, M., Bentsen, K.D., Hoybye, G., Eghoje, K., Christoffersen, P.: Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis. Lancet 1984/II: 241–244
Spahr, L., Vingerhoets, F., Lazeyras, F., Delavelle, J., du Pasquier, R., Giostra, E., Mentha, G., Terrier, F., Hadengue, A.: Magnetic resonance imaging and proton spectroscopic alterations correlates with parkinsonian signs in patients with cirrhosis. Gastroenterology 2000; 119: 774–781
Steindl, P.E., Finn, B., Bendok, B., Rothke, S., Zee, P.C., Blei, A.T.: Disruption of the diurnal rhythm of plasma melantonin in liver cirrhosis. Wien. Klin. Wschr. 1997; 109: 741–746
Such, J., Guardiola, J.V., de Juan, J., Casellas, J.A., Pascual, S., Aparicio, J.R., Sola-Vera, J., Perez-Mateo, M.: Ultrastructural characteristics of distal duodenum mucosa in patients with cirrhosis. Eur. J. Gastroenterol. Hepatol. 2002; 14: 371–376
Sugimura, T., Tsuji, Y., Sakamoto, M., Kotoh, K.: Long term prognosis and prognostic factors of liver cirrhosis in the 1980s. J. Gastroenterol. Hepatol. 1994; 9: 154–161
Tabaru, A., Shirohara, H., Moriyama, A., Otsuki, M.: Effects of branched-chain-enriched amino acid solution on insulin and glucagon secretion and blood glucose level in liver cirrhosis. Scand. J. Gastroenterol. 1998; 33: 853–859
Tarao, K., Rino, Y., Ohkawa, S., Tamai, S., Miyakawa, K., Takakura, H., Endo, O., Yoshitsugu, M., Watanabe, N., Matsuzaki, S.: Close association between high serum alanine aminotransferase levels and multicentric hepatocarcinogenesis in patients with hepatitis C virus-associated cirrhosis. Cancer 2002; 94: 1787–1795
Thaler, H.: Hepatitis und Zirrhose. Dtsch. Med. Wschr. 1975; 100: 1018–1025
Thorgeirsson, S.S., Grisham, J.W.: Molecular pathogenesis of human hepatocellular carcinoma. Nature Genet. 2002; 31: 339–343
Trevisani, F., Merli, M., Savelli, F., Valeriano, V., Zambruni, A., Riggio, O., Caraceni, P., Domenicali, M., Bernardi, M.: QT interval in patients with non-cirrhotic portal hypertension and in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt. J. Hepatol. 2003; 38: 461–467
Tripathi, D., Therapondos, G., Lui, H.F., Stanley, A.J., Hayes, P.C.: Haemodynamic effects of acute and chronic administration of low-dose carvedilol, a vasodilating beta-blocker, in patients with cirrhosis and portal hypertension. Alim. Pharm. Ther. 2002; 16: 373–380
Ukleja, A., Scolapio, J.S., McConnell, J.P., Dickson, R.C., Nguyen, J.H., O’Brien, P.C.: Serum and hepatic vitamin E assessment in cirrhotics before transplantation. J. Parent. Ent. Nutr. 2003; 27: 71–73
Ukleja, A., Scolapio, J.S., McConnell, J.P., Spivey, J.R., Dickson, R.C., Nguyen, J.H., O’Brien, P.C.: Nutritional assessment of serum and hepatic A levels in patients with cirrhosis. J. Parent. Ent. Nutr. 2002; 26: 184–188
Urbain, D., Muls, V., Makhoul, E., Jeghers, O., Thys, O., Ham, H.R.: Prognostic significance of hepatic venous pressure gradient in medically treated alcoholic cirrhosis: comparison to aminopyrine breath test. Amer. J. Gastroenterol. 1993; 88: 856–859
Valeriano, V., Funaro, S., Lionetti, R., Riggio, O., Pulcinelli, G., Fiore, P., Masini, R., deCastro, S., Merli, M.: Modification of cardiac function in cirrhotic patients with and without ascites. Amer. J. Gastroenterol. 2000; 95: 3200–3205
Van Buuren, H.R., ter Borg, P.C.J.: Transjugular intrahepatic portosystemic shunt (TIPS): Indications and long-term patency. Scand. J. Gastroenterol. 2003; 38 (Suppl. 239): 100–104
Venturini, I., Cioni, G., Turrini, F., Gandolfo, M., Modonesi, G., Cosenza, R., Miglioli, L., Cristani, A., D’Alimonte, P., de Santis, M., Zeneroli, M.L.: Mesenteric vein thrombosis: a rare cause of abdominal pain in cirrhotic patients. Two case reports. Hepato-Gastroenterol. 1998; 45: 44–47
Verne, G.N., Soldevia-Pico, C., Robinson, M.E., Spicer, K.M., Reuben, A.: Autonomic dysfunction and gastroparesis in cirrhosis. J. Clin. Gastroenterol. 2004; 38: 72–76
Vilgrain, V., Lebrec, D., Menu, Y., Scherrer, A., Nahum, H.: Comparison between ultrasonographic sings and the degree of portal hypertension in patients with cirrhosis. Gastrointest. Radiol. 1990; 15: 218–222
Vitellas, K.M., Tzalonikou, M.T., Bennett, W.F., Vaswani, K.K., Bova, J.G.: Cirrhosis: Spectrum of findings on unenhanced and dynamic gadolinium-enhanced MR imaging. Abdom. Imag. 2001; 26: 601–615
Wagner, S., Doss, M.-O., Wittekind, C., Bäcker, U., Meessen, D., Schmidt, F.W.: Erythrohepatische Protoporphyrie mit rasch progredienter Leberzirrhose. Dtsch. Med. Wschr. 1989; 114: 1837–1841
Wanless, I.R., Wong, F., Blendis, L.M., Greig, P., Heathcote, E.J., Levy, G.: Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension. Hepatology 1995; 21: 1238–1247
Watanabe, S., Kimura, Y., Nishioka, M., Ohkawa, M., Kozeki, M., Yano, M., Hashimoto, N.: Assessment of hepatic functional reserve in cirrhotic patients by computer tomography of the caudate lobe. Dig. Dis. Sci. 1999; 44: 2554–2563
Weismann, K., Christensen, E., Dreyer, V.: Zinc supplementation in alcoholic cirrhosis. A double-blind clinical trial. Acta Med. Scand. 1979; 205: 361–366
Winston, C.B., Schwartz, L.H., Fong, Y.M., Blumgart, L.H., Panicek, D.M.: Hepatocellular carcinoma: MR imaging findings in cirrhotic livers and noncirrhotic livers. Radiology 1999; 210: 75–79
Wong, F., Massie, D., Hsu, P., Dudley, F.: Indometacin-induced renal failure in patients with well-compensated cirrhosis. Gastroenterology 1993; 104: 869–876
Yamauchi, M., Takeda, K., Sakamoto, K., Ohata, M., Toda, G.: Effect of oral branched chain amino acid supplementation in the late evening on the nutritional state of patients with liver cirrhosis. Hepatol. Res. 2001; 21: 199–204
Yang, Y.A., Lin, H.C., Lee, W.C., Hou, M.C., Lee, F.Y., Chang, F.Y., Lee, S.D.: One-week losartan administration increases sodium excretion in cirrhotic patients with and without ascites. J. Gastroenterol. 2002; 37: 194–199
Zen, Y., Sunagozaka, H., Tsuneyama, K., Matsutomi, K., Terasaki, S., Kaneko, S., Kobayashi, K., Nakanuma, Y.: In complete septal cirrhosis associated with Wegener’s granulomatosis (case report). Liver 2002; 22: 388–393
Zhang, S.C., Wang, W., Ren, W.Y., Dai, Q.A., He, B.M., Zhou, K.: Effects of lactulose on intestinal endotoxin and bacterial translocation in cirrhotic rats. Clin. Med. J. 2003; 116: 767–771
Zoli, M., Cordiani, M.R., Marchesini, G., Iervese, T., Morselli Labate, A.M., Bonazzi, C., Bianchi, G., Pisi, E.: Prognostic indicators in compensated cirrhosis. Amer. J. Gastroenterol. 1991; 86: 1508–1513
Zoli, M., Merkel, C., Magalotti, D., Gueli, C., Grimaldi, M., Gatta, A., Bernardi, M.: Natural history of cirrhotic patients with small esophageal varices: a prospective study. Amer. J. Gastroenterol. 2000; 95: 503–508
Zullo, A., Rinaldi, V., Meddi, P., Folino, S., Lauria, V., Diana, F., Winn, S., Attili, A.F.: Helicobacter pylori infection in dyspeptic cirrhotic patients. Hepatogastroenterol. 1999; 46: 395–400
Rights and permissions
Copyright information
© 2008 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
(2008). Liver cirrhosis. In: Hepatology Textbook and Atlas. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-76839-5_35
Download citation
DOI: https://doi.org/10.1007/978-3-540-76839-5_35
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-76838-8
Online ISBN: 978-3-540-76839-5
eBook Packages: MedicineMedicine (R0)